Trading for BIO tokens is currently underway in the pre-market phase on Mexc and Bybit. The official Binance listing is set for January 3, 2025. BIO is the first token from the DeSci segment to debut on major centralized exchanges.
Here’s what’s interesting: until now, BIO tokens were only available as rewards for directly funding DAOs within the BIO project. In the BIO Telegram community, participants have calculated the “price” of BIO tokens for those who supported funding rounds. This “price” equals the total funds raised in a round divided by the number of tokens distributed. Based on this data, the acquisition price ranged from $0.039 to $0.096.
Today, BIO tokens are trading on Bybit and Mexc pre-markets for $0.90 - 10 to 20 times higher than their original price. This feels reminiscent of the ICO boom. While “decentralized science” sounds serious, many early supporters likely didn’t fully understand what they were funding. Yet today, they’ve potentially earned 1500% returns on their investments.
Such dynamics could trigger FOMO among market participants who missed BIO’s surge. We may soon see a wave of DeSci projects where people invest without understanding the economics of decentralized scientific organizations. Once again, the crypto space might see the return of easy money.
By the way, DeSci pioneers Rifamithin (RIF) and Urolithin A (URO) are available for exchange at rabbit.io.